Drugs / Trivalent OPV Sanofi Pasteur
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT01870206 Comparator | Jun → Dec 2013 | poliomyelitis | Birmex | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Trivalent OPV Sanofi Pasteur | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01870206 ↗ |
| Modality | Vaccine | “OPV vaccine produced in Vero cells by Sanofi Pasteur” NCT01870206 ↗ |